Cargando…
Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer
Genetic profiling of urine cell free DNA (cfDNA) has not been evaluated in advanced prostate cancer. We performed whole genome sequencing of urine cfDNAs to identify tumor-associated copy number variations in urine before and after initiating androgen deprivation therapy in HSPC stage and docetaxel...
Autores principales: | Xia, Yun, Huang, Chiang-Ching, Dittmar, Rachel, Du, Meijun, Wang, Yuan, Liu, Hongyan, Shenoy, Niraj, Wang, Liang, Kohli, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094965/ https://www.ncbi.nlm.nih.gov/pubmed/27127882 http://dx.doi.org/10.18632/oncotarget.9027 |
Ejemplares similares
-
Cell‐free DNA copy number variations in plasma from colorectal cancer patients
por: Li, Jian, et al.
Publicado: (2017) -
Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer
por: Huang, Jinyong, et al.
Publicado: (2022) -
Multiplex Digital PCR to Detect Amplifications of Specific Androgen Receptor Loci in Cell-Free DNA for Prognosis of Metastatic Castration-Resistant Prostate Cancer
por: Du, Meijun, et al.
Publicado: (2020) -
Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
por: Shenoy, Niraj, et al.
Publicado: (2016) -
Microarray analysis of copy-number variations and gene expression profiles in prostate cancer
por: Han, Yuping, et al.
Publicado: (2017)